---
title: "\"Performance\" INT MEDICAL's annual net profit is 219 million RMB, an increase of 14%, with a final dividend of 32 cents"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280899648.md"
description: "INT MEDICAL announced its 2025 annual performance, with revenue of 1.065 billion RMB, an increase of 25.1% year-on-year. It recorded a net profit of 219 million RMB, a growth of 14%, with earnings per share of 1.26 RMB. A final dividend of 0.23 RMB was declared"
datetime: "2026-03-29T07:08:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280899648.md)
  - [en](https://longbridge.com/en/news/280899648.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280899648.md)
---

# "Performance" INT MEDICAL's annual net profit is 219 million RMB, an increase of 14%, with a final dividend of 32 cents

INT MEDICAL (01501.HK) announced its performance for the fiscal year 2025, with revenue of 1.065 billion RMB, an increase of 25.1% year-on-year. It recorded a net profit of 219 million RMB, a growth of 14%, with earnings per share of 1.26 RMB. A final dividend of 0.23 RMB per share was declared

### Related Stocks

- [01501.HK](https://longbridge.com/en/quote/01501.HK.md)

## Related News & Research

- [Comey eyes new 'anti-weaponization' fund: 'I'm guessing I'll be in line'](https://longbridge.com/en/news/286948735.md)
- [Trump faces record-low approval on inflation as retirees struggle](https://longbridge.com/en/news/286834439.md)
- [Trump Delivers Confused Rambling After Claiming ’Every Agency' Has 'Scum'](https://longbridge.com/en/news/287086760.md)
- [09:06 ETHarmony Comes to the Massachusetts State House as The Platters® Prepare Their Musical Love Letter to the World](https://longbridge.com/en/news/286918739.md)
- [Mabwell Wins Wider China Indications for Denosumab Biosimilar as Global Push Accelerates](https://longbridge.com/en/news/287103520.md)